| | NOVEMBER 202119named iPET, which is a cloud-based solution to revolutionize feasibility, study conduct and patient enrollment. i-PET facilitates global connectivity allowing to achieve fastest ever feasibility survey/study across the globe, and it enhances site performance with respect to recruitment by cross references and its unique patient enrolment process. We are constantly integrating lots of innovative technologies in right way to bring everything on one single platform.Where is iDD Research Solutions positioned in the current clinical trial industry of India and what are your thoughts on the present and future scenarios of this space? Are you affiliated to any of the accreditation bodies?Being one of the fastest growing Indian CRO, all the credit goes to the excellent team that we have. Starting from a new joinee to the ones in leadership position, you will see exceptional energy and commitment level across the ladder. Currently our focus is to keep the growth rate going and for the conventional CRO model we are now aiming to increase the international businesses to more than 50% of total business, which is currently around 20%. As mentioned above the key shift in business is going to be our conversion as a Digital CRO fully, which we see happening in next two years.About accreditations, yes we are an ISO 9001-2015 certified company and we are also the member in DIA. As far as Quality is concerned, we stick to our core mantra - " By quality, Through Quality, For Quality".The reason for having this as the mantra for this year is because we have revamped most of our process and systems and we have doubled our QMS team strength and have also moved some of our best talents into QMS. Moreover, our processes are made in a way where our QMS becomes integrated part of all department to ensure it works as a support system to control the process rather than a monitoring system to correct process errors. As the Founder, what strategies that you are devising to reach a stronger position in the Clinical Trial domain? What is the roadmap set ahead for iDD Research Solutions?At iDD Research Solutions, keep believe in a simple and straightforward strategy - "Stick to Process". I have firm belief that if you stick to process, it will ensure that it takes care of all turbulence and short falls which are unavoidable in the journey. Process is very important for any industry and when it comes to CRO industry process maters the most. At, iDD Research Solutions, we spend enough in making implementable process, creating systems to track process adherence and have robust review systems to ensure constant improvisation.The current COVID-19 pandemic situation has definitely led to the booming of CR industry and as far as iDD's business is concerned, from the operational perspective, we have seen 3x growth consecutively in last 4 quarters and expect to close with minimum 4x growth this year, in comparison to 2020.With full fledged launch of iSMARTTMwe are also in talks for collaboration/mergers. We want to keep working towards creating a more favouring environment for healthcare & society.Going ahead, we are also aiming for a complete shift to pure Tech enabler/Digital CRO to empower the way clinical trials are conducted across the globe. Our move towards collaboration/merger is to muscle our self for the global launch of iSMART. I believe in a very simple principle - `only thing that is humanly possible is being sincere towards your attempts' and that's what I have been doing all these years and I wish to continue the same. Dream will look like Distraction. Commitment will look like Adamancy.. Confidence will look like Ego. Passion will look like madness. Sincerity will look like stupidity. Till you win. only till you winD.T. Arasu,Founder & MD
< Page 9 | Page 11 >